advertisement
|
|
|
|
|
advertisement
|
|
| |
Top Stories
Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /
The companies have entered into a collaboration agreement to develop and commercialize three of Genmab's early-stage investigational bispecific antibody product candidates.
/ read more /
|
|
| |
Industry News
The Biomedical Catalyst has been relaunched, meaning that innovative biotech companies will have the opportunity to access a share of £30 million (US$38 million) in grant funding.
/ read more /
Leo Pharma, medical dermatology specialist, has announced that the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for tralokinumab.
/ read more /
More Industry News
|
|
|
Supplier News
Catalent will provide vial filling and packaging capacity to AstraZeneca at its manufacturing facility in Anagni, Italy, for the large-scale commercial manufacturing of the University of Oxford’s adenovirus vector-based COVID-19 vaccine candidate.
/ read more /
|
|
|
|
advertisement
|
|
|
|
Oxford Biomedica, has signed a collaboration agreement with the not-for-profit organization, the Vaccines Manufacturing and Innovation Centre, to provide the UK with its first strategic vaccine development and advanced manufacturing capability.
/ read more /
More Supplier News
|
|
|
advertisement
|
|
Bio/Pharma News
The companies have entered into a development and manufacturing agreement for Anthos Therapeutics’ abelacimab for treating thrombotic disorders.
/ read more /
The candidates will be used by the Vaccine Research Center, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
/ read more /
More Bio/Pharma News
|
|
advertisement |
|
The 2020 PDA Pharmaceutical Manufacturing Data Science Workshop will be going virtual! Join us July 13-16 for this four-part webinar series to build data-driven dashboards with live feedback from industry data science experts using traditional and advanced analytics to improve your project and process evaluations. Explore the agenda online and register for this specialized Workshop today!
/
View Now / |
| |
Regulatory News
Will efforts to limit all returns on investment drive biopharma companies away from developing much-needed interventions for COVID-19?
/ read more /
The agency has added a COVID-19 innovation resource page and an education resources page to its website.
/ read more /
More Regulatory News
|
| |
|
Featured Topics |
|
PEER-REVIEW RESEARCH
The authors compare formulations containing citrate with other buffers in reducing subcutaneous injection-site pain and discuss a formulation and excipients selection strategy.
/ read more /
|
|
|
DEVELOPMENT
Increasing prevalence of drug misuse and abuse is driving a heightened and more stringent approach to abuse-deterrent formulations.
/ read more /
|
|
|
| |
|
FORMULATION
Connected delivery solutions can provide value to industry and patients, through improved medication adherence and outcome optimization.
/ read more /
|
|
|
|
|
MANUFACTURING
Advances in intelligent technologies for pharmaceutical packaging improve online productivity, authenticate product, and boost patient adherence.
/ read more /
|
|
|
eBOOKS
 |
The Pharmacopoeia Compliance Series features a description of ways bio/pharma companies can participate in monograph development, a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.
|
|
|
|
|
|
